Controlled Substance Monitoring and Drugs of Abuse Testing
JH · Effective Oct 1, 2015
23 active Medicare policies list F20.9, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
7 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of F20.9 |
|---|---|---|
| Electroconvulsive Therapy | Sep 21, 2023 | Covered |
| Hemodialysis for Schizophrenia | May 5, 2023 | Covered |
| Optic Nerve and Retinal Imaging Methods | May 17, 2023 | Covered |
| Quantitative EEG (Brain Mapping) | Apr 25, 2023 | Covered |
| Quantitative, Functional and Connectomic Analysis of Brain MRI | Oct 4, 2023 | Covered |
| Vagus Nerve Stimulation | Feb 9, 2024 | Covered |
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
JL · Effective Oct 1, 2024
JL · Effective Jan 1, 2026
National · Effective Jun 4, 2026
JL · Effective Oct 1, 2025
National · Effective Apr 17, 2025
J6 · Effective Apr 1, 2026
J5 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Apr 16, 2026
J6 · Effective Oct 1, 2026
| Policy | Effective | Status of F20.9 |
|---|---|---|
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |